+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07782216

Studying Protein Biomarkers in the Early Phase of Traumatic Brain Injury and Cardiac Arrest in Emergency and Prehospital Care

Led by University of Pecs · Updated on 2026-09-29

477

Participants Needed

4

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying how specific proteins called neurobiomarkers behave in the very first minutes and hours after acute brain injuries like traumatic brain injury TBI and cardiac arrest CA. These conditions cause brain cells to release proteins into the blood, which might help doctors assess injury severity, guide treatment, and predict outcomes. The study focuses on measuring these markers during the hyperacute phase, a time that is not well understood, especially in emergency and prehospital settings. Participants include three groups those with severe TBI or polytrauma treated before hospital arrival, cardiac arrest patients treated before hospital arrival, and severe TBI patients enrolled upon emergency department admission. Blood samples are taken multiple times starting in the prehospital phase and continuing up to 24 hours after hospital admission. No experimental treatments are given all participants receive standard emergency and intensive care. During the study, blood samples are analyzed for various neurobiomarkers, microRNAs, and metabolites using specialized laboratory methods. Researchers track outcomes like mortality up to 30 days and neurological status to understand how biomarker levels relate to injury severity and recovery. The study is conducted at multiple centers including emergency departments, intensive care units, and ambulance services, with a planned enrollment of 477 participants and follow-up extending to 12 months for long-term outcomes.

CONDITIONS

Brief Title

Critical Hyperacute Assessment Research On Neurobiomarker Kinetics in Acute Brain Injury

Research Team

E

Endre Czeiter, MD, PhD

Á

Ábel Papp, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here